Skip to main content



Local Cdiff information for Nebraska

Nebraska

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Nebraska.



Local Cdiff information for Nebraska

Nebraska

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Nebraska.

Providers


Regulation


C. diff Infections

Total Reported Cases: 452
Hospital Onset: 452
Community Onset: Not reported
Related Deaths: Not reported

Available Reports

Annual Progress based on SIR: 0.83

State Reporting Laws

Data Submission Required: Yes
Data Publicly Available: No
Data Validated: No
Facility-specific Data Publicly Reported: No
LTC Facility Submission Required: No
LTC Facility Data Publicly Reported: No
Law/Regulation: 173 NAC 1

State Contact

Maureen R. Tierney, M.D., MSc.
Healthcare Associated Infections Coordinator
Nebraska Dept. of Health & Human Services
Division of Public Health
301 Centennial Mall
Lincoln, 68509
(402) 471-6549
(402) 471-3601

CLINICAL TRIALS


ROAR

Official Title: REBYOTA™ for the Prevention of Recurrence of Clostridioides Difficile Infection (CDI) in Adult Patients: An Observational Study
Trial No. NCT05835219
Type: Observational
Recruitment: Recruiting
Sponsor: Ferring Pharmaceuticals
Contact: Global Clinical Compliance
833-548-1402
Gender: All
Age: 18 Years and older